Retatrutide

Retatrutide

Retatrutide is a multi-receptor agonist medication currently in development for weight management and type 2 diabetes treatment. By targeting three key receptors—GLP-1, GIP, and glucagon—it helps regulate appetite, metabolism, and blood sugar levels. Early clinical trials show promising results in reducing body weight, improving blood sugar control, and enhancing overall metabolic health.

SKU: Reta5 | Reta10 | Reta15 | Reta20
Category:

CAS #: 2381089-83-2

Molecular Formula: C221H342N46O68

Molecular Weight: approx. 4,731.33 g/mol

Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors. The glucagon activation enhances energy expenditure and potentially reduces liver fat, in addition to the benefits of appetite regulation and glycemic control.

  • Demonstrates even greater weight loss potential compared to Tirzepatide in clinical trials, with patients achieving up to 24% body weight reduction in some studies.
  • Highly effective in improving HbA1c levels and overall glycemic control, making them viable options for type 2 diabetes management.

*Each order comes with syringes, alcohol pads, and bacteriostatic water*

*Shipping only available in the continental U.S.*

All products on this site are for research and development use only. Products are not for human consumption of any kind.

Dosing

Retatrutide Dosing Protocol

Starting Dose:
2mg once weekly for 4 weeks.

Titration:
Increase to 4mg once weekly for at least 4 weeks.
If needed and tolerated, increase 6mg, then 8mg weekly, and so on, each after 4 weeks.

Maintenance Dose: 2mg, 4mg, 6mg, 8mg, 10mg, or 12mg once weekly.

Missed Dose: Take within 4 days; otherwise, skip and resume the regular schedule.

This is not medical advice.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide”

Your email address will not be published. Required fields are marked *

Related products